VivoSeq
Other

PRP

0

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

PRP is an early-stage landscape with 0 programs across 1 company. The most active players are PYC Therapeutics.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

PYC Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed4 · 40%
Unknown status2 · 20%
Active, not recruiting2 · 20%
Not yet recruiting1 · 10%
Recruiting1 · 10%

Clinical Trials

Trial Activity

10 trials

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
Recruiting·PPYC Therapeutics·Phase 1·NCT06455826·12 enrolled
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects
Active, not recruiting·PPYC Therapeutics·Phase 1·NCT05902962·20 enrolled
PRP vs AD-SVF in Addition to Marrow Stimulation for Knee Chondral Lesion
Active, not recruiting·—·Phase 4·NCT07255547·80 enrolled
PrP-targeting siRNA Safety & Mechanism Study
Not yet recruiting·—·Phase 1·NCT07444580·30 enrolled
Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects
Completed·HHorus University·Phase 2·NCT07108933·16 enrolled
Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim
Completed·AAndrews Research & Education Foundation·N/A·NCT05573386·15 enrolled
Effect of the Adjunctive IVB Before PRP
Completed·KKyungpook National University Hospital·Phase 4·NCT01504724·30 enrolled
Effect of PRP With Physiotherapy on Shoulder Impingement
Completed·IIstinye University·N/A·NCT07410208·54 enrolled
PRP Therapy to m. Gluteus Medius During THA
Unknown status·—·N/A·NCT02607462·80 enrolled
PRP vs PRP+IVC for Severe nPDR
Unknown status·RRuijin Hospital·N/A·NCT03863535·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)